Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 15, 2026
Time trends in strategies for postoperative Crohn's disease management and long-term surgical recurrence: ENEIDA registry dataGisela Piñero, Míriam Mañosa, Guillermo Bastida, et al.
Gut|December 25, 2025
TL1A-activated T cells remodel the rectal mucosa in patients with Crohn's disease with perianal fistulising diseaseVictoria Gudiño, Jae Won Cho, Berta Caballol, et al.
Bone Marrow Transplantation|May 25, 2021
Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendationsRaffaella Greco, Tobias Alexander, Joachim Burman, et al.
Gut|November 21, 2015
Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's diseaseAranzazu Jauregui-Amezaga, Montserrat Rovira, Pedro Marín, et al.
JAMA|December 17, 2015
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical TrialChristopher J Hawkey, Matthieu Allez, Miranda M Clark, et al.
Nature Communications|July 26, 2023
Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel diseaseAlba Garrido-Trigo, Ana M Corraliza, Marisol Veny, et al.
Frontiers in Immunology|October 10, 2022
Experimental and genetic evidence for the impact of <i>CD5</i> and <i>CD6</i> expression and variation in inflammatory bowel diseaseSergi Casadó-Llombart, María Velasco-de Andrés, Cristina Català, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or CyclosporineDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Lancet (London, England)|October 16, 2012
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trialDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 14, 2025
New insights into thiopurine toxicity: The contribution of rare XDH variants to myelotoxicityHugo Tejera-Pérez, Alejandro Velasco-Ruiz, María Chaparro, et al.
Pageof 14